Reflusod
Oral Solution for the Treatment of Severe Symptoms of Gastroesophageal Reflux
REFLUSOD is a medical device (MD) in oral emulsion form, provided in a bottle with a dosing syringe, specifically indicated for the treatment of symptoms of moderate to severe gastroesophageal reflux disease (GERD). Its innovative emulsion formulation ensures high product compliance
The effectiveness of REFLUSOD is based on the synergistic action of its components:
- The Sodium Alginate and low molecular weight Hyaluronic Acid create an effective mechanical barrier at the esophageal level, counteracting the rise of gastric contents. Hyaluronic Acid also helps promote healing of damage to the esophageal mucosa.
- The extract of Myrrh (Myrrh e.s. tit. 30% polysaccharides) provides a soothing and protective action on the mucosa, reducing irritation.
- The Simethicone acts on reflux gas, improving relief.
A distinctive advantage of REFLUSOD is the absence of known side effects for hypertensive or nephropathic patients, making it a safe option for these categories as well.
Therapeutic indications:
- Moderate to severe gastroesophageal reflux disease (GERD).
- Symptoms associated with acid reflux, such as burning and heartburn.
- Treatment of reflux gas.
- Protective action on damaged esophageal mucosa.
FarmaImpresa Group, a certified manufacturer of medical devices, dietary supplements, and dermocosmetics, offers REFLUSOD ready to market or available as private label, with full technical and regulatory support.
Thanks to its innovative emulsified form and its triple barrier, soothing, and anti-flatulence action, REFLUSOD is the solution for treating symptoms of severe gastroesophageal reflux.
